4,5 Diabetic peripheral neuropathy (DPN), the most common form of DN, is characterized by distal symmetric polyneuropathy, leading to sensory loss, pain, and motor dysfunction in the extremities and is a primary cause of foot ulcers and lower-limb amputations in diabetes patients
Figure 2: Categorical weight loss of either 5%, 10%, or 15% in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Researchers should review all relevant safety data sheets and institutional guidelines before commencing any experimental work with this peptide
The nasal spray's matrix is designed to preserve peptide integrity even when stored or transported under variable lab conditions
10.1111/j.1365-2982.2007.01079.x 24 JaglinM.RhimiM.PhilippeC.PonsN.BruneauA.GoustardB.et al